Alexandria, Virginia — The American Association for the Study of Liver Diseases (AASLD) proudly announces the 2025 Distinguished Award recipients, honoring individuals whose outstanding contributions have shaped the field of hepatology and advanced the care of patients with liver disease.
Each year, AASLD presents its most prestigious awards to recognize exceptional leadership, mentorship, service, and advocacy across the liver community.
The 2025 honorees include:
- Distinguished Achievement Award
Gyongyi Szabo, MD, PhD, FAASLD
Harvard Medical School, Beth Israel Deaconess Medical Center and Beth Israel Lahey Health, Boston, Massachusetts
- Distinguished Clinician Educator/Mentor Award
Lewis R. Roberts, MB, ChB, PhD, FAASLD
Mayo Clinic Rochester, Minnesota
- Distinguished Service Award
Robert J. Fontana, MD, FAASLD
University of Michigan Hospitals and Health Centers, Ann Arbor, Michigan
The 2025 Distinguished Advocacy Award recipient will be unveiled closer to The Liver Meeting® (TLM). This recognition highlights the incredible work being done to champion liver health.
These awardees will be recognized and celebrated during TLM, taking place Nov. 7–11, 2025, in Washington, D.C.
To view the awardee profiles, as well as previous Distinguished Award recipients, click here.
For more information about TLM 2025 and the Awards & Honors Gala, please click here.
###
About AASLD
The American Association for the Study of Liver Diseases (AASLD) is the leading organization of scientists and health care professionals committed to preventing and curing liver disease. AASLD fosters research that leads to improved treatment options for millions of liver disease patients and advances the science and practice of hepatology through educational conferences, training programs, professional publications, and partnerships with government agencies and sister societies.